Medicare’s "Bridge" Program Offers Temporary Lifeline for GLP-1 Weight Loss Drugs, But Questions Linger
For years, Medicare beneficiaries seeking the groundbreaking GLP-1 medications for weight loss faced a definitive "no." However, a new initiative, dubbed the "Medicare GLP-1 Bridge short-term demonstration," is poised to change that narrative, albeit with significant caveats. Starting July 1, 2026, eligible individuals will gain access to certain GLP-1 drugs, like Wegovy (which shares the…
